Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 35

1.

Charting the neglected West: The social system of Guinea baboons.

Fischer J, Kopp GH, Dal Pesco F, Goffe A, Hammerschmidt K, Kalbitzer U, Klapproth M, Maciej P, Ndao I, Patzelt A, Zinner D.

Am J Phys Anthropol. 2017 Jan;162 Suppl 63:15-31. doi: 10.1002/ajpa.23144.

2.

Sex and friendship in a multilevel society: behavioural patterns and associations between female and male Guinea baboons.

Goffe AS, Zinner D, Fischer J.

Behav Ecol Sociobiol. 2016;70:323-336. Epub 2016 Jan 22.

3.

Assessing adaptability and reactive scope: Introducing a new measure and illustrating its use through a case study of environmental stress in forest-living baboons.

MacLarnon AM, Sommer V, Goffe AS, Higham JP, Lodge E, Tkaczynski P, Ross C.

Gen Comp Endocrinol. 2015 May 1;215:10-24. doi: 10.1016/j.ygcen.2014.09.022. Epub 2014 Oct 18.

PMID:
25458172
4.

Mother-offspring transmission and age-dependent accumulation of simian foamy virus in wild chimpanzees.

Blasse A, Calvignac-Spencer S, Merkel K, Goffe AS, Boesch C, Mundry R, Leendertz FH.

J Virol. 2013 May;87(9):5193-204. doi: 10.1128/JVI.02743-12. Epub 2013 Feb 28.

5.

Detection of retroviral super-infection from non-invasive samples.

Goffe AS, Blasse A, Mundry R, Leendertz FH, Calvignac-Spencer S.

PLoS One. 2012;7(5):e36570. doi: 10.1371/journal.pone.0036570. Epub 2012 May 8.

6.

Wild chimpanzees infected with 5 Plasmodium species.

Kaiser M, Löwa A, Ulrich M, Ellerbrok H, Goffe AS, Blasse A, Zommers Z, Couacy-Hymann E, Babweteera F, Zuberbühler K, Metzger S, Geidel S, Boesch C, Gillespie TR, Leendertz FH.

Emerg Infect Dis. 2010 Dec;16(12):1956-9. doi: 10.3201/eid1612.100424.

7.

High prevalence, coinfection rate, and genetic diversity of retroviruses in wild red colobus monkeys (Piliocolobus badius badius) in Tai National Park, Cote d'Ivoire.

Leendertz SA, Junglen S, Hedemann C, Goffe A, Calvignac S, Boesch C, Leendertz FH.

J Virol. 2010 Aug;84(15):7427-36. doi: 10.1128/JVI.00697-10. Epub 2010 May 19.

8.

Isolation of a transmissible agent resembling rubella virus from an apparently healthy human embryo lung cell culture.

Butler M, Goffe AP.

J Gen Virol. 1968 Mar;2(2):285-90. No abstract available.

PMID:
4297605
9.

Further information on the antibody response to wart virus.

Goffe AP, Almeida JD, Brown F.

Lancet. 1966 Sep 17;2(7464):607-9. No abstract available.

PMID:
4161962
10.

Contaminant viruses in two live virus vaccines produced in chick cells.

Harris RJ, Dougherty RM, Biggs PM, Payne LN, Goffe AP, Churchill AE, Mortimer R.

J Hyg (Lond). 1966 Mar;64(1):1-7. No abstract available.

11.

Antibody to wart virus in human sera demonstrated by electron microscopy and precipitin tests.

Almeida JD, Goffe AP.

Lancet. 1965 Dec 11;2(7424):1205-7. No abstract available.

PMID:
4158822
12.

Studies on tumours developing in hamsters following inoculation of SV-40 virus and BHK-21 cells.

Hale JH, Goffe AP, Tomlinson BE, Ingham HR, Waller MP, Selkon JB.

Br J Exp Pathol. 1965 Dec;46(6):598-606. No abstract available.

13.

A DIPLOID HUMAN CELL STRAIN WITH CHRONIC INAPPARENT RUBELLA INFECTION.

GOFFE A.

Arch Gesamte Virusforsch. 1965;16:469. No abstract available.

PMID:
14322914
14.

VACCINATION OF INFANTS WITH LIVING ATTENUATED MEASLES VACCINE (EDMONSTON STRAIN) WITH AND WITHOUT GAMMA-GLOBULIN.

BENSON PF, BUTLER NR, GOFFE AP, KNIGHT GJ, LAURENCE GD, MILLER CL, POLLOCK TM.

Br Med J. 1964 Oct 3;2(5413):851-3. No abstract available.

15.

FURTHER OBSERVATIONS ON VACCINATION IN INFANCY WITH ORAL POLIOMYELITIS VACCINE AND DIPHTHERIA, TETANUS, PERTUSSIS VACCINE.

BUTLER NR, BENSON PF, URQUHART J, GOFFE AP, KNIGHT GJ, POLLOCK TM.

Br Med J. 1964 Aug 15;2(5406):418-20. No abstract available.

16.

Active immunization against measles.

Goffe A.

Sci Basis Med Annu Rev. 1964:151-68. Review. No abstract available.

PMID:
5321090
17.

Vaccination in infancy with oral poliomyelitis vaccine and diphtheria, tetanus, pertussis vaccine.

BENSON PF, BUTLER NR, COSTELLO JM, URQUHART J, BARR M, GOFFE AP, KNIGHT GJ, POLLOCK TM.

Br Med J. 1963 Mar 9;1(5331):641-3. No abstract available.

18.

Vaccination against measles in general practice.

GOFFE AP, WOODALL JT, TOCKMAN E, PAULET JD, MANSER IN, FRANKLIN LM.

Br Med J. 1963 Jan 5;1(5322):26-8. No abstract available.

19.

Poliomyelitis--the future--prevention and control. The vaccines and their problems.

GOFFE AP.

Public Health. 1962 May;76:221-9. No abstract available.

PMID:
13899546
20.

Antibody response in infants to the poliomyelitis component of a quadruple vaccine.

HILLARY IB, MEENAN PN, GOFFE AP, KNIGHT GJ, KANAREK AD, POLLOCK TM.

Br Med J. 1962 Apr 21;1(5285):1098-102. No abstract available.

21.

Small-scale trial with Sabin attenuated type 1 poliovirus vaccine in a semi-closed community.

HOSKINS JM, HOBSON D, UDALL V, MADLAND T, GOFFE AP, STUART-HARRIS CH, HERZOG EG.

Br Med J. 1962 Mar 17;1(5280):747-53. No abstract available.

22.

Vaccination against measles. I. Preparation and testing of vaccines consisting of living attenuated virus.

GOFFE AP, LAURENCE GD.

Br Med J. 1961 Nov 11;2(5262):1244-6. No abstract available.

23.

Vaccination against measles. II. Clinical trial in Nigerian children.

COLLARD P, HENDRICKSE RG, MONTEFIORE D, SHERMAN P, VAN DER WALL HM, MORLEY D, GOFFE AP, LAURENCE GD, POLLOCK TM.

Br Med J. 1961 Nov 11;2(5262):1246-50. No abstract available.

24.

Vaccination aginst measles. III. Clinical trial in British children.

ALDOUS IR, KIRMAN BH, BUTLER N, GOFFE AP, LAURENCE GD, POLLOCK TM.

Br Med J. 1961 Nov 11;2(5262):1250-3. No abstract available.

25.

Vaccination of adults with a British oral poliomyelitis vaccine prepared from Sabin strains.

GOFFE A, POLLOCK TM, SHAND FL.

Br Med J. 1961 Jul 29;2(5247):272-5. No abstract available.

26.

Poliomyelitis virus in sewage in 1951.

GOFFE AP, BEVERIDGE JJ, MACCALLUM FO, PHIPPS PH.

Mon Bull Minist Health Public Health Lab Serv. 1960 Jan;19:9-18. No abstract available.

PMID:
13850460
27.

A small-scale trial of type III attenuated living poliovirus vaccine.

CLARKE SK, GOFFE AP, STUART-HARRIS CH, HERZOG EG.

Br Med J. 1958 Nov 15;2(5106):1188-93. No abstract available.

28.

Discussion on the geographical distribution of poliomyelitis.

GALE AH, GOFFE AP, LOGAN WP.

Proc R Soc Med. 1955 Nov;48(11):931-42. No abstract available.

29.

Quarantine measures in poliomyelitis.

GOFFE AP, PARFITT EM.

Lancet. 1955 Jun 4;268(6875):1172-5. No abstract available.

PMID:
14382536
30.

Typing of poliomyelitis viruses by complement fixation.

LE BOUVIER GL, LAURENCE GD, PARFITT EM, JENNENS MG, GOFFE AP.

Lancet. 1954 Sep 11;267(6837):531-2. No abstract available.

PMID:
13193068
31.

Poliomyelitis; recent developments in laboratory techniques.

GOFFE AP.

Proc R Soc Med. 1953 Dec;46(12):1001-4. No abstract available.

32.

Studies on urinary carriage of enteric group organisms. III.

ARCHER GT, GOFFE AP, RITCHIE A.

J R Army Med Corps. 1952 Apr;98(4):237-40; concl. No abstract available.

PMID:
14939261
33.

Studies on urinary carriage of enteric group organisms.

ARCHER GT, GOFFE AP, RITCHIE A.

J R Army Med Corps. 1952 Mar;98(3):189-97; contd. No abstract available.

PMID:
14918246
34.

Studies on urinary carriage of enteric group organisms.

ARCHER GT, GOFFE AP, RITCHIE A.

J R Army Med Corps. 1952 Feb;98(2):125-31; contd. No abstract available.

PMID:
14909129
35.

Studies on urinary carriage of enteric group organisms. II. Classification of urinary carriers, and the diagnostic value of urinary antibody tests.

ARCHER GT, GOFFE AP, RITCHIE A.

J R Army Med Corps. 1952 Jan;98(1):40-7. No abstract available.

PMID:
14909120

Supplemental Content

Support Center